Pla2g2d | phospholipase A2, group IID
Physiological systems
18 / 24 physiological systems tested
5 Significantly impacted by the knock-out
Homeostasis/metabolism Immune system Hematopoietic system Behavior/neurological Renal/urinary system
13 No significant impact
6 Not tested
Data collections
Gene metrics:3Significant phenotypes
0Associated diseases
Expression examined in:48Adult tissues
46Embryo tissues
decreased urine magnesium level | 1 supporting dataset | Pla2g2dtm1.1(KOMP)Vlcg | homozygote | Early adult | 4.4x10-5 | ||
hyperactivity | 1 supporting dataset | Pla2g2dtm1.1(KOMP)Vlcg | homozygote | Early adult | 2.21x10-5 | ||
decreased leukocyte cell number | 1 supporting dataset | Pla2g2dtm1.1(KOMP)Vlcg | homozygote | Early adult | 4.74x10-6 |
| | | | | | | | | |
External links
No external links available for Pla2g2d.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Pla2g2dtm1(KOMP)Vlcg | Reporter-tagged deletion allele (with selection cassette) | | ES Cell mouse |
Pla2g2dtm1.1(KOMP)Vlcg | Reporter-tagged deletion allele (post Cre, with no selection cassette) | | mouse |
Pla2g2dtm373680(L1L2_Bact_P) | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector |